TP53 and hepatocellular carcinoma: Our study on the regulatory effect of miR-199a-3p on HCC also found that miR-199a-3p could activate the p53 signaling pathway by targeting the expressions of CDK1/CCNB1, thereby inhibiting the development of HCC.